Evidence map›Paper›PMID 36260979›Full record

ArticleNanotechnology2022

Freestanding high-aspect-ratio gold masks for low-energy, phase-based x-ray microscopy.

Olga V Makarova, Ralu Divan, Nicolaie Moldovan, David A Czaplewski, Michela Esposito, Marco Endrizzi, Cha-Mei Tang, Joseph D Ferrara, Alessandro Olivo

Open access · greenAbstract read
In one paragraph

Article in Nanotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Olga V MakarovaCreatv MicroTech Inc., Chicago IL 60612, United States of America.ORCID 0000-0002-8255-8547
Ralu DivanCenter for Nanoscale Materials, Argonne National Laboratory, IL 60439, United States of America.ORCID 0000-0002-6343-942X
Nicolaie MoldovanCenter for Nanoscale Materials, Argonne National Laboratory, IL 60439, United States of America.ORCID 0000-0001-5715-4957
David A CzaplewskiCenter for Nanoscale Materials, Argonne National Laboratory, IL 60439, United States of America.ORCID 0000-0003-2262-0908
Michela EspositoDepartment of Medical Physics and Biomedical Engineering, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-6827-1240
Marco EndrizziDepartment of Medical Physics and Biomedical Engineering, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-7810-2301
Cha-Mei TangCreatv MicroTech Inc., Potomac MD 20854, United States of America.ORCID 0000-0003-3017-0732
Joseph D FerraraRigaku Americas Corp, The Woodlands, TX 77371, United States of America.ORCID 0000-0001-9167-5246
Alessandro OlivoDepartment of Medical Physics and Biomedical Engineering, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-7150-2951
Argonne National Laboratory · USUniversity College London · GBCreatv MicroTech (United States) · USHCA Healthcare · US

Funding

A soft X-Ray Phase-Based Microscope for Biomedical ApplicationsR01EB028829 · NIBIB · RIGAKU AMERICAS CORPORATION · PI FERRARA, JOSEPH DAVID, MAKAROVA, OLGA V. · 2020 to 2023
$2.1M
NIBIB NIH HHS R01 EB028829
6 · The paper itself

Abstract

High-resolution, x-ray phase contrast microscopy, a key technique with promising potential in biomedical imaging and diagnostics, is based on narrow-slit high-aspect-ratio gold gratings. We present the development, fabrication details, and experimental testing of the freestanding 10

Indexed as

freestanding gold membrane maskgold electroplatingphase contrast imagingSi DRIEthin film deposition

Identifiers

PMID36260979
PMCPMC9662782
OpenAlexW4306826978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.